# Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females

> **NCT04965350** · PHASE3 · COMPLETED · sponsor: **Shanghai Zerun Biotechnology Co.,Ltd** · enrollment: 1100 (actual)

## Conditions studied

- HPV Infection

## Interventions

- **BIOLOGICAL:** Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Pichia pastoris)

## Key facts

- **NCT ID:** NCT04965350
- **Lead sponsor:** Shanghai Zerun Biotechnology Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-20
- **Primary completion:** 2022-04-27
- **Final completion:** 2022-05-16
- **Target enrollment:** 1100 (ACTUAL)
- **Last updated:** 2023-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04965350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04965350, "Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy Females". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04965350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*